Cited by 64Computational Drug Discovery MethodsAnimal testing and alternativesMachine Learning in Healthcare

A review on the recent applications of deep learning in predictive drug toxicological studies

Sinha, Krishnendu, Ghosh, Nabanita, Sil, Parames C.·2023·Chemical Research in Toxicology

Abstract

Drug toxicity prediction is an important step in ensuring patient safety during drug design studies. While traditional preclinical studies have historically relied on animal models to evaluate toxicity, recent advances in deep-learning approaches have shown great promise in advancing drug safety science and reducing animal use in preclinical studies. However, deep-learning-based approaches also face challenges in handling large biological data sets, model interpretability, and regulatory acceptance. In this review, we provide an overview of recent developments in deep-learning-based approaches for predicting drug toxicity, highlighting their potential advantages over traditional methods and the need to address their limitations. Deep-learning models have demonstrated excellent performance in predicting toxicity outcomes from various data sources such as chemical structures, genomic data, and high-throughput screening assays. The potential of deep learning for automated feature engineering is also discussed. This review emphasizes the need to address ethical concerns related to the use of deep learning in drug toxicity studies, including the reduction of animal use and ensuring regulatory acceptance. Furthermore, emerging applications of deep learning in drug toxicity prediction, such as predicting drug-drug interactions and toxicity in rare subpopulations, are highlighted. The integration of deep-learning-based approaches with traditional methods is discussed as a way to develop more reliable and efficient predictive models for drug safety assessment, paving the way for safer and more effective drug discovery and development. Overall, this review highlights the critical role of deep learning in predictive toxicology and drug safety evaluation, emphasizing the need for continued research and development in this rapidly evolving field. By addressing the limitations of traditional methods, leveraging the potential of deep learning for automated feature engineering, and addressing ethical concerns, deep-learning-based approaches have the potential to revolutionize drug toxicity prediction and improve patient safety in drug discovery and development.

Integrity signals

Registry

Crossref · 10.1021/acs.chemrestox.2c00375

Cites

251 of 251 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Sinha, K., Ghosh, N., & Sil, P. C.
Affiliations
  • Jhargram Raj College (IN)
  • Maulana Azad College (IN)
  • Bose Institute (IN)
Corresponding author
  • Sinha, Krishnendu
  • Sil, Parames C.
Venue
Chemical Research in Toxicology
Published
2023-08-10
Volume
36
Issue
8
Pages
1174-1205
ISSN
  • 0893-228X (ISSN-L)
  • 1520-5010
OpenAlex
W4385741356
Cited by
64
References
251
Citations by year
2026: 20 · 2025: 25 · 2024: 15 · 2023: 4
FWCI
1.09
Type
journal article
Language
en
Open access
closed
Locations
  • Chemical Research in Toxicology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Physical Sciences › Computer Science › Computational Theory and Mathematics › Computational Drug Discovery Methods
  • Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
  • Physical Sciences › Computer Science › Artificial Intelligence › Machine Learning in Healthcare
Keywords
drug toxicity prediction, predictive toxicology, deep learning, animal use reduction, preclinical toxicity testing, automated feature engineering, drug-drug interactions, regulatory acceptance, model interpretability, high-throughput screening data, genomic data, drug safety assessment
MeSH terms
Deep Learning, Animals, Drug Interactions, Genomics, Drug Discovery, Drug-Related Side Effects and Adverse Reactions

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review